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Summary.-A simple method has been developed which facilitates the detailed
cytogenetic analysis of proliferating tumour cells within clusters and colonies arising
from clonogenic tumour stem cells in biopsy samples of human cancers. The method
uses a simple agar cloning technique for human tumours, which provides marked
enhancement in the number of cases with observable mitotic activity and the number
of mitotic figures available for detailed karyotypic assessment. The frequency of
mitotic figures in cluster and colony samples is much greater than is attainable with
standard chromosomal techniques. This novel approach should prove to be a powerful
tool for the study of human tumour karyology.
TUMOUR STEM CELLS, key cells within a
neoplasm, possess the potential for re-
peated cycles of proliferation and serve as
the seeds of metastasis. They may give
rise to secondary tumour colonies at dis-
tant sites in the body and this clonogenic
property has been used as the basis for in
vitro assays to study the biological prop-
erties ofthese cells.
The value ofclonogenic assays ofhuman
haemopoietic malignancies and solid
tumours is now well established (Metcalf,
1977; Hamburger & Salmon, 1977a).
However, although much is known about
the proliferation and kinetics of haemo-
poietic and tumour stem cells, information
on the cytogenetics of clonogenic tumour
cells remains extremely limited (Moore &
Metcalf, 1973; Najfeld et al., 1978). Cyto-
genetic studies of human tumour cells
cloned in soft agar have been made only
on tumours of haemopoietic origin. Cur-
rent techniques involve hand-picking of
individual colonies followed by manual
dispersal before harvest of cells for cyto-
logical assessment (Moore & Metcalf,
1973). Studies of human solid tumours
using direct or short-term culture methods
have also been beset with technical diffi-
culties arising from inherently low mitotic
indices and morphologically sub-optimal
mitotic figures.
Our laboratory recently developed a
simple soft-agar colony assay for human
tumour stem cells, which can be used with
established techniques for stem cell studies
to analyse fresh biopsy samples from a
variety of human tumours (Hamburger &
Salmon, 1977a,b; Hamburger et al., 1978;
Jones et al., 1979). We report here the
development and application of a simple
approach for studying the cytogenetics of
human tumour colonies grown in soft agar.
METHODS
Culture preparation.-Cells from human
solid tumours or malignant ascites were cul-
tured by the human tumour stem-cell assay
described by Hamburger & Salmon (1977a).
Briefly, 1 ml underlayers containing the
appropriate admixture of nutrient medium
(with or without conditioned medium) and
growth factors in 0.5%0 agar are placed into
35mm plastic Petri dishes. A single-cell sus-
pension is prepared by mincing and teasing
the freshly biopsied tumour in culture
medium, followed by passage of cells and
aggregates through a series of stainless-steelJ. M. TRENT AND S. E. SALMON
screens, filtration through sterile gauze, and
then through needles of decreasing gauge.
The resulting single cells (2-5 x 105 total)
are then suspended in 1 ml of 0.3% molten
agar containing enriched medium plus 15%
horse serum. This is then plated over a lml
0.5% agar underlayer. Cultures are then
incubated at 37°C with 7.5% CO2 in air for
periods of up to 21 days. Morphology of
developing colonies was observed serially
with inverted phase microscopy as well as on
stained samples of intact, wet, or air-dried
colony-containing plating layers (Salmon &
Liu, 1979; Salmon & Buick, 1979).
Harvesting for cytogenetic analysis.-Agar
cultures incubated at 37°C are initially over-
layed with 2-5 ml ofenriched medium CMRL-
1066 containing 0 1IUM colchicine. While a lh
colchicine incubation is standard, up to 16 h
exposure facilitates study of cultures with
limited cellular proliferation. After the col-
chicine incubation, the entire plating layer
(containing the desired colonies) is detached
from the feeder layer by gently agitating the
overlying culture medium with a Pasteur
pipette. Usually, the 0.3% agar plating layer
quickly comes free from the 0-5% agar feeder
layer which remains attached to the plate.
However, if both layers remain attached, a
small rent between the agar layers can be
made with a Pasteur pipette. The plating
layer may then be removed by gentle spurts
of the overlying culture medium by the pip-
ette followed by manually swirling the plate.
The plating layer together with the overlying
culture medium is then gently poured into a
15ml conical centrifuge tube, and the feeder
layer remaining attached to the plate is dis-
carded. The plating layer is then centrifuged
for 5 min at 150 g, the supernatant is carefully
removed, and the pelleted clusters or colonies
(within the residual agar) are resuspended in
fresh 0-075M KCI at 37°C for 25 min. Cultures
are then recentrifuged for 5 min and the
supernatant discarded. Seven ml of fresh,
cold fixative (3:1 absolute methanol to glacial
acetic acid) is added, and the suspension is
mixed vigorously with a vortex. The hypo-
tonic treatment and subsequent agitation of
the plating layer causes release of intact
clusters or colonies (which grow as multi-
cellular spheroids) from all but a vestige ofthe
separated plating layer. Air-dried slides are
prepared after 10min exposure to fixative
(excess material can be stored in fixative at
-9°C). Standard Giemsa, G-banding (Sun
et al., 1973) C-banding (Miller et al., 1976) or
N-banding (Goodpasture & Bloom, 1975) is
then applied to the slide. Vestiges of the
agar plating layer do not appear to inter-
fere with the various chromosome-banding
techniques.
The number of mitoses found in "back-
ground" cells vs those found in the clusters
was analysed by examining undisturbed
plating layers with a modification of the per-
manent slide technique described by Salmon
& Buick (1979). Briefly, cultures are first
exposed to colchicine in a manner similar to
that previously described. Then, the entire
intact plating layer is removed from the
feeder layer and placed into a disposable
plastic weighing tray. The overlying culture
medium is then gently decanted with a
Pasteur pipette and 24 ml of 0-075M KCI
prewarmed to 37°C is added to the tray. After
a 25min incubation at 37°C the hypotonic is
gently removed and 10-15 ml of fresh cold
fixative is added to the tray. Ten min later
the supernatant is removed and the plating
layer is washed twice more with fixative. The
entire plating layer is then carefully poured
on to a microscope slide, allowed to dry in
the air, and stained with 3% Giemsa (Gurr's
R-66) for 2-3 min. Although this procedure
does allow identification and localization of
mitoses, it is not preferred because of diffi-
culty in obtaining satisfactory chromosome
spreading and banding.
To compare the mitotic index from our
short-term agar cultures with that obtained
by previously described techniques, chromo-
some harvesting of fresh tumour biopsy
samples was simultaneously performed by the
"direct" harvesting technique of Shiloh &
Cohen (1978) and the "liquid culture method"
of Kakati et al. (1975).
Cell counts for mitotic index.-Total cell
counts per slide were obtained by using a
Bausch and Lomb Omnicon Alpha 500 image
analyser coupled to a microscope with an
automated stage and a Hewlett Packard
9815A programmable calculator. A com-
parison of eye and Omnicon cell counts on
microscope slides has shown them to be
equally accurate (r=0-93). After determining
the total cell number, the same slide is then
reviewed in its entirety with conventional
microscopy for observable mitoses to obtain
the mitotic index. This is expressed as the
total number of mitotic figures counted over
the total number of cells counted.
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RESULTS AND DISCUSSION
We have used the soft-agar colony
assay to study tumour colony cells in a
wide variety of human cancers (Table I).
TABLE I. Cytogenetics of human tumours
cloned directly in agar culture
Tumour types
successfully analyse(l
(evidence for
neoplastic origin*)
Carcinomas
Modal
chromo-
some
assess-
ment
successful
/Total (%)
Blad(ler (M, C) 4/8 (50)
Breast (M, C) 2/2 (100)
Kidney (1, C) l/l
Lung (M, C) 2/2 (100)
Ovary (M, C) 15/22 (68)
Uterus (M, C) 2/3 (66)
cervix an(l corpus
Sarcoma and other malignancies
Diffuse lymphoma (M, B, C) 1/3 (33)
Melanoma (M, B, C) 5/10 (50)
Multiple myeloma (M, B, C) 3/8 (38)
Neuroblastoma (M, B, C) 2/3 (66)
Totals 37/62 (60)
Bandling
analysis
successful
/Total (o%)
1/1
1/1
NAt
NA
8/9 (89)
1/1
NA
1/3 (33)
NA
1/1
13/16 (81)
* Morphology (M), Biomarker (B), Cytogenetic
(C).
t Not attempte(l.
Tumours also stuccessfuilly cultured, buit not yet
studliedl cytogenetically: carcinomas; adreinal (M),
colon (M, B), pancreas (M), prostate (M), thyroi(d
(Ml, B), upper respiratory tract (M); other malig-
nancies include: chronic lymphocytic leukaemia
(M, B), Ewing's tumour (M), fibrosarcoma (M),
glioblastoma (AM), liposarcoma (M), nodlular lym-
plioma (Al, B, C), rlabdomyocsarcoma (XM).
In cultures from over 500 biopsy samples,
tuimour colony formation has been ob-
tained in 5000 of all tumours. Evidence
for neoplastic origin of these colonies is
obtained with morphological, biomarker
(e.g. immunofluorescence for carcino-
embryonic antigen or myeloma proteins)
and cytogenetic techniques (Table I).
Cultures selected for chromosome
analysis displayed mitotic activity from
the early cluster stage ( < 20 cells) to the
colony stage ( > 40 cells) of clonal growth.
Generally, clusters can be harvested at
2-7 days and colonies after 7-14 days of
incubation. Samples taken from the early
cluster stage of clonal growth proved
optimal for detailed chromosome-banding
analysis, whereas evaluation of modal
number and gross karyotypic abnormality
was possible in colonies.
Of the 23 histological types of cancer
which we have grown successfully, our
cytogenetic method was found useful for
10 tumour types. While detailed karyo-
typic assessment of all tumours grown by
this technique has not yet been made,
tumour colonies or clusters from epi-
thelial and non-epithelial cancers tested
with our new technique have provided
sufficient mitoses for standard chromo-
some analysis. The enhancement in the
number of analysable mitoses which re-
sults from our approach is the result of
the selective circumstances of growth in
agar culture. Specifically, while 500,000
cells are plated in each Petri dish, only
50-200 tumour stem cells from that
population usually proliferate. Their pro-
liferation can be readily identified, and
clusters or colonies derived from them
harvested with the previously described
technique. Growth in agar culture of non-
haemopoietic cells is generally accepted as
putative evidence of neoplastic growth.
Normal stromal cells (e.g. fibroblasts) do
not proliferate in this system; thus, avail-
able mitoses from clusters and colonies are
derived from the neoplastic progenitor
population. Whilst lymphoid progenitors
can also be grown in soft agar, they re-
quire specific stimulators of growth other
than those used by us (Metcalf, 1977).
Loose granulocytic colonies occasionally
appear in these cultures. However, culture
conditions are not optimal for normal
myeloid growth. Evidence of the selective
growth of tumour cells over normal cells
in our assay system is the observation that
normal diploid mitoses have not been seen
in any ofthe 37 tumour samples studied to
date.
An important feature of this procedure
is the ability to isolate intact colonies and
clusters in situ, omitting the tedious and
selective picking of individual colonies.
This allows a unique and perhaps signifi-
cant visualization of colony morphology,
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FIG. 1. Human bladder-carcinoma colony in soft agar. Mitoses are peripherally distributed around
a necrobiotic centre. Giemsa, x 1417.
as well as assessment of the location and
number of mitotic figures within gener-
ating tumour colonies (Fig. 1).
Comparison of our method with direct
(non-clonogenic) methods (Shiloh & Cohen,
1978; Kakati et al., 1975) for fresh biopsy
material demonstrated the most consistent
and desirable feature of our assay: a
markedly increased mitotic index. Esti-
mates of the mitotic index of colony
samples based only upon the clonogenic
fraction have shown a mitotic yield as
much as several thousand times that of
direct samples. This marked enrichment
oftumour chromosomes is due both to the
selective proliferation of tumour cells
with suppression of normal cellular
elements induced by agar culture, and to
the liberation from agar of colonies and
clusters at the time of harvest. The reader
should recognize that our calculation of
the enhancement of mitoses due to this
procedure can, at best, be only an esti-
mate, because of the difficulty of calcu-
lating recovery of morphological entities
from agar and the extreme scarcity of
mitoses in direct preparations. However,
by using an image analyser we have calcu-
lated mitotic index on the basis of the
total number of cells per sample. These
results are presented in Table II. Exami-
nation of intact plating layers has demon-
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TABLE II.-Mitotic index* of human strated that mitoses are almost exclusively
tumour cells by direct, liquid, and agar localized to generating colonies and clus-
culture techniques ters. However, disaggregation of a small
Sample T r tnumber of mitoses from colonies and SAmplenTumouarcinoma tp Diet LqdAgr clusters can occur during the processing 1 Adenocarcinoma ° . breast 0-0022 0-0010 0-17 steps. If the enhancement in tumour
2 Adenocarcinoma mitoses in agar culture is calculated on the
ovary 0-0070 1.70 basis only of cells in clusters or colonies
3 Adenocarcinoma (the clonogenic and therefore proliferative
ovary - 0-0030 0-60 fraction) a mitotic index of up to 9% has
4 Adenocarcinoma been observed. Thus, the increase in the
ovary 0-0032 0(28 mitotic index beyond direct preparations
5 Adenocarcinoma is further multiplied, up to several
breast 0-0022 0-0041 0-04 thousand-fold. Although direct tumour
*Total ofmitotic figures samples from some malignant ascites may Total cells x 100 contain a large proliferative compartment
FIG. 2. Banded chromosomes from tumour cells of Patient EV. (A) G-banded metaphase displaying
a variety of complex chromosome changes (see Fig. 3); (B) C-banded metaphase displaying heavily
stained regions ofconstitutive heterochromatin; (C) N-banding showing silver staining ofnucleolus-
organizer regions. Metacentric as well as the normal acrocentric silver staining is observed (arrows).
(D) Multiple copies of double minute bodies (arrows) in addition to numerous tumour chromosomes,
stained by Giemsa.
59
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Fio 3.-G-banded karotype from Patient EV. A variety of chromosome abnormalities, including:
del(1)(pter-+q25:), del(2)(pter-*q23:), del(6)(pter-+qI5:), + 4 unidentified markers.
(e.g. MI = 1%) this occurrence is ex-
tremely rare (Kakati & Sandberg, 1978).
The numerical enhancement observed
from our studies indicates substantially
increased tumour cell recovery in a large
number and wide variety of solid and
ascitic tumours. Additionally, in the 5
cases in which direct harvesting and
colony analysis have been compared,
similarities in modal number, structural
variants, and marker chromosomes have
been found.
Examples of the application of G-, C-,
and N-banding to tumour cells grown 72 h
in the colony-assay system are depicted
in Fig. 2. Tumour cells were procured
from patient E.V., a 47-year-old woman
in whom the diagnosis of ovarian adeno-
carcinoma had just been established and
had not received treatment with chemo-
therapy or radiotherapy. Samples from
the patient's primary solid tumour and a
malignant ascites were obtained simul-
taneously, and cultured separately with
the stem-cell assay. Giemsa analysis re-
vealed a modal count of 38 in both direct
harvest and colony samples, with G-
banding revealing a wealth of karyotypic
variability. The most common karyotypic
aberrations within the multiple stem lines
present in this tumour were: 38, -X, -17,
-22, del(1)(pter-*q25:), del(2)(pter-+q23:),
del(6)(pter--qI5:), + 1-4 unidentified
marker chromosomes (Fig. 3). The obser-
vation in this tumour of at least 4 major
karyotypically unique progenitor-cell
populations is consistent with the sugges-
tion that our assay system captures a
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representative sample of the clonogenic
fraction within tumour samples. The
structural and numerical intra-tumour
chromosome variation between clonogenic
populations suggests that substantial
karyotypic "evolution" (progressive clonal
heterogeneity) (Nowell, 1977) has already
occurred in the stem-cell pool of the
tumour from this untreated patient. The
ability to perform chromosome-banding
analysis by G-banding (Fig. 2a) to demon-
strate constitutive heterochromatin by
C-banding (Fig. 2b) and selectively to
silver-stain transcriptionally active cist-
rons for 18S and 28S ribosomal RNA by
N-banding (Fig. 2c) was extremely useful
in characterizing the complexly re-
arranged tumour-cell chromosomes in this
cancer. Chromosome-banding of direct
samples from this patient, although simi-
lar in modal number, provided far less
information, owing to an extremely low
mitotic index and morphologically sub-
optimal chromosomes. Interestingly, cyto-
genetic comparisons between the colony-
forming tumour cells in both the patient's
ascites and solid-tumour biopsy sample
revealed a similar modal chromosome
number, though a higher percentage of
polyploidy was found in tumour cells from
the primary site.
In addition to the marked structural
chromosomal variation between this
patient's tumour cells, 10% of all
mitoses displayed dozens of double
minute bodies (dms) (Fig. 2d). The finding
of dms in tumour cells from cluster and
colony samples from this patient is strong
support for the neoplastic origin of these
cells (Barker & Hsu, 1979). The occurrence
of dms and acquired drug resistance have
recently been associated with specific gene
amplification in established animal tumour
lines (Alt et al., 1978). Cytogenetic analysis
of spontaneous human tumours may dis-
play similar or additional changes in
relation to resistance to methotrexate or
other anticancer drugs. Cytogenetic com-
parisons between the clonogenic fractions
before and after chemotherapy in our
system may facilitate identification of
unique progenitor cells resistant to specific
anticancer drugs.
The procurement of chromosomes from
human solid tumours by direct harvesting
techniques has normally failed to provide
mitotic figures morphologically suitable
for Giemsa-banding. The effects of this
restriction on human solid-tumour kary-
ology is profound. Although epithelial
cancers are the most common of human
tumours, they have rarely been analysed
with chromosome-binding techniques. Re-
cent reviews have shown that less than
5%0 of all banded chromosomal analyses
of human tumours published to date have
involved carcinomas (Mitelman & Levan,
1978). With increasing clinical application
of cytogenetics to human malignancies
(Golomb et al., 1978; Trent & Davis, 1979)
detailed studies using chromosome-band-
ing of human epithelial cancers is needed.
Methodological improvement in the cyto-
genetic analysis ofsolid tumours and their
ascites has long been sought. Use of our
method should greatly facilitate detailed
karyotypic assessment of a variety of
human tumours and may provide im-
portant new basic and clinical observations
relevant to cancer.
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